The DigniCap Scalp Cooling System has been used around the world since 2001. In 2015, after a multi-center clinical trial, DigniCap became the first scalp cooling system to receive FDA clearance in the United States.

COMPANY PROFILE

Dignitana is a Swedish medical technology company, now part of the Paxman Group as of June 1, 2025. 

Dignitana subsidiaries include Dignitana AB in Lund, Sweden; Dignitana US Inc. in Dallas, Texas; and Dignitana SRL in Milan, Italy — all of which are now wholly owned by Paxman AB (publ). 

The company markets and supports The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. In 2017, Dignitana received an expanded clearance from the FDA, allowing DigniCap to be used by patients receiving chemotherapy to treat solid tumors from breast cancer as well as those from prostate, ovarian, uterus, lungs and other tissues. 

STRONGER TOGETHER

Merging with Paxman to form a new, unified group enables valuable collaboration and connections, the sharing of new perspectives, and leverage of each other’s strengths – all with the goal to improve patient outcomes. The two companies share the same patient-centric values, both with the aim of making scalp cooling accessible to all those who want it. This includes any future chemotherapy side effect management technologies and as such, now share the same vision.  

PURPOSE

Over 20 million people and their families face the life-altering impact of cancer each year. Dignitana exists to give them access and choice to proven side-effect management solutions, supporting patients worldwide to prevent chemotherapy-induced alopecia.  

CORE VALUES

Dignitana is united by a set of Core Values that define our culture and identity. These comprise the principles for our work with each other and our interactions with customers. We value: 

Passion
We believe in the work that we do every day to improve a patient’s quality of life.

Compassion
We put patients first. We care about the customer experience and treat patients and clinicians with respect, empathy, and understanding.

Innovation
We leverage our diversity of ideas and experience and lead the way in technological advancements.

Collaboration
We are stronger together and support each other and our clinical partners.

Excellence
We produce clinically superior products and provide industry-leading customer service.